The facility, which more than doubled R&D lab space to facilitate process transfer and development, also includes dedicated and separate microbial fermentation development, protein purification, ...

MISSISSAUGA, Ontario, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix ®), a life sciences innovator, manufacturer, and ...

BURLINGTON, Mass., April 2, 2025 /PRNewswire/ -- SEKISUI Diagnostics, a global medical diagnostics manufacturer, announces the launch of the Metrix ® COVID/Flu Test, the second assay on the Metrix ® ...

ABBOTT PARK, Ill., April 14, 2015 /PRNewswire/ -- Today, Abbott (NYSE: ABT) and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide. Coagulation tests ...

- Sekisui Diagnostics to expand point of care testing portfolio with the FastPack® IP System from Qualigen Inc. - Qualigen expands their commercial reach through relationship with Sekisui Diagnostics ...

BURLINGTON, Mass., March 5, 2024 /PRNewswire/ -- SEKISUI Diagnostics, a global medical diagnostics manufacturer, has received EUA clearance for the OSOM Flu SARS-CoV-2 Combo Test for use in ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme Corporation (Nasdaq: GENZ) today announced that it has entered into an asset purchase agreement under which Sekisui Chemical Co., Ltd. will acquire Genzyme’s ...

Sekisui Diagnostics has significantly expanded its point of care (POC) diagnostics product line through a recent partnership agreement with Qualigen, Inc. Sekisui Diagnostics is now the exclusive ...

It was biotech's version of "buy-one-get-one" for Genzyme business units on Thursday. Sekisui Chemical Co. Ltd., of Osaka and Tokyo, started the business day Thursday by buying one – Genzyme's ...